4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-052841
EVP & Chief Financial Officer sold 6,799 shares at $5.56 ($37,782)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Byrne Jason EVP & Chief Financial Officer | 2025-11-17 | Sale 10b5-1 | −6,799 | $5.56 | $37,782 | 110,701 | D |
| Open-market sales · 6,799 sh · avg $5.56 · $37,782 | |||||||
Loading xslF345X05/wk-form4_1763495228.xml…